4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001628280-26-041566
Options or other derivatives
- Director acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Foster-Cheek Kaye I Director | 2026-06-05 | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | D | ||
Loading xslF345X06/wk-form4_1780949818.xml…